“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed. A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency… Read More »
However, the European Medicines Agency (EMA) said on Thursday there is no indication the vaccine has caused these symptoms. The EMA said in a statement: “There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. “The vaccine’s benefits continue to outweigh its risks and… Read More »
AstraZeneca announced that it was restarting phase three coronavirus vaccine trials after they were paused when a participant became ill. The pharmaceutical giant announced the resumption on Saturday after the trials were put on hold on Sunday. The patient in question, a woman, was from the United Kingdom and reportedly suffered a rare spinal cord… Read More »